Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Sep 15, 2026
YieldMax MSTR Option Income Strategy ETF (MSTY): +21% Over 30 Days on Bitcoin Rebound

YieldMax MSTR Option Income Strategy ETF (MSTY): +21% Over 30 Days on Bitcoin Rebound

Key Takeaways

  • MSTY rose roughly 21% over the past 30 days, climbing from about $12.55 to $15.13 as the underlying MicroStrategy (now Strategy) shares rallied.
  • Over the last quarter, the fund is still down about 9%, reflecting a sharp June-to-August drawdown followed by a partial recovery.
  • The move was driven primarily by a rebound in Bitcoin and Strategy's resumed Bitcoin purchases, which lifted the value of the call-option book.
  • As a synthetic covered-call fund, MSTY captures only a portion of underlying upside, capping its gains relative to the stock it tracks.
  • Weekly distributions remain a core feature, though a meaningful portion of payouts may be classified as return of capital.

Understanding the YieldMax MSTR Option Income Strategy ETF (MSTY)

The YieldMax MSTR Option Income Strategy ETF (MSTY) is an actively managed exchange-traded fund that aims to generate current income while offering exposure to the share price of Strategy Inc (formerly MicroStrategy, Nasdaq: MSTR), with a built-in limit on potential gains. It does not hold Strategy stock directly. Instead, the fund employs a synthetic covered-call approach consisting of three main elements: synthetic long exposure to MSTR through a long call and short put, short-dated call options sold against that position, and U.S. Treasury securities as collateral.

Its portfolio generally includes 23 to 29 holdings, centered on short-term U.S. Treasury bills and notes, a money-market fund, and a series of MSTR call options. The net expense ratio stands at 1.03%, and the fund is non-diversified. By writing calls with strikes typically 5% to 15% above the current price, MSTY gives up most upside beyond that range while remaining fully exposed to declines. This setup means the fund tends to lag MSTR in strong rallies but follows its drawdowns closely. I also checked this using Tickeron’s AI Screener to see how the fund compares to other single-stock income strategies.

Price Performance Over the Past 30 Days Versus the Quarter

Over the past 30 days, MSTY advanced approximately 21%, moving from a close near $12.55 to about $15.13. The advance was not steady; the fund reached a low in the low-to-mid $12 range in mid-August before rising sharply in late August and early September.

The quarterly view shows a different picture. Three months earlier, MSTY traded near $16.66, so the fund remains roughly 9% lower over the quarter despite the recent rebound. The period featured a steep decline from June into August, a multi-week basing phase, and then the partial recovery. From what I see, the 30-day gain needs to be viewed against this still-negative quarterly trend.

Drivers Behind the 30-Day Price Move

The main catalyst came from a rebound in Bitcoin and in Strategy shares, which climbed roughly 45% over the month as Bitcoin rose around 24%. Strategy resumed Bitcoin purchases in late August after a roughly ten-week pause, acquiring about 4,603 Bitcoin at an average of $80,318 per coin and bringing its total holdings to approximately 845,050 Bitcoin. That announcement helped fuel a single-session gain of more than 17% in MSTR, which flowed through to higher values for MSTY’s call-option positions.

Because MSTY writes short-dated calls above the current price, the fund captured only the portion of the rally up to its strike caps rather than the full move. Treasury holdings supplied a stable income component, while the synthetic long exposure and written calls accounted for the price appreciation. Sentiment toward Bitcoin-treasury companies improved with the broader crypto recovery, supporting demand for the strategy.

What Shaped Performance Over the Quarter

The quarter was shaped by a sharp drawdown in Bitcoin and Strategy’s equity. Between late June and early August, Strategy sold roughly 7,000 Bitcoin at prices between about $59,000 and $64,000 per coin to handle preferred-stock obligations, and its shares fell more than 50% on a trailing 12-month basis. Those declines pulled MSTY lower, since the fund’s synthetic exposure stayed fully exposed to the downside.

Second-quarter results highlighted the pressure: Strategy reported a net loss driven largely by a multibillion-dollar unrealized loss on its digital-asset holdings. The fund’s high distribution yield also includes a substantial return of capital component rather than purely generated income, which can reduce net asset value over time. The recent partial recovery reflects improved sentiment and Bitcoin’s bounce rather than any structural change in the fund itself.

Outlook and Key Variables to Monitor

The most important factors for MSTY going forward remain Bitcoin’s price path and Strategy’s capital-markets activity. Strategy’s model relies on issuing equity and preferred securities to fund Bitcoin purchases, and its shares function as a leveraged proxy for the cryptocurrency. Ongoing volatility in Bitcoin would likely pass through directly to MSTR and then to MSTY.

Investors should also track the composition of the fund’s distributions. A high yield that includes sizable return of capital can erode NAV over time, and the cap from written call options limits participation in extended rallies. Interest-rate expectations and Treasury yields influence collateral income, while regulatory developments around digital assets could affect sentiment. The fund’s structure offers minimal downside protection despite the income focus, so volatility and underlying price levels stay central to watch in the months ahead.

Enhancing Analysis with Tickeron Tools

In my own research process, I find Tickeron’s AI-powered platforms helpful for quickly comparing derivative-income strategies and spotting patterns across sectors. The AI Screener, in particular, lets me filter ETFs and stocks by technical indicators, volatility, and performance metrics in a structured way that complements traditional review. I also use the AI Trend Prediction Engine from time to time to gauge potential direction for holdings like MSTY under different market scenarios.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MSTY

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


MSTY's RSI Oscillator recovers from overbought zone

The 10-day RSI Oscillator for MSTY moved out of overbought territory on August 28, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 13 instances where the indicator moved out of the overbought zone. In 13 of the 13 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 27 of 28 cases where MSTY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for MSTY turned negative on September 11, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 20 similar instances when the indicator turned negative. In 19 of the 20 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MSTY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

MSTY broke above its upper Bollinger Band on August 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 14, 2026. You may want to consider a long position or call options on MSTY as a result. In 40 of 44 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.

MSTY moved above its 50-day moving average on August 19, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MSTY crossed bullishly above the 50-day moving average on August 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 7 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Following a +5.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where MSTY advanced for three days, in 131 of 145 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

The Aroon Indicator entered an Uptrend today. In 66 of 76 cases where MSTY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 87%.

Industry description

The investment seeks current income; the fund’s secondary investment objective is to seek exposure to the share price of the common stock of MicroStrategy Incorporated d/b/a Strategy, subject to a limit on potential investment gains. The fund is an actively managed ETF that seeks current income while maintaining the opportunity for exposure to the share price of the common stock of MicroStrategy Incorporated, subject to a limit on potential investment gains. The fund is non-diversified.
View a ticker or compare two or three
MSTY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Details
Category
Derivative Income
Address
United States
Phone
N/A
Web
N/A
Interact to see
Advertisement
AVAV shares dropped approximately 10% in premarket trading on March 11, 2026, following a disappointing Q3 fiscal 2026 earnings report released after the prior session's close. Q3 revenue of $408.0 million came in far below analyst consensus of approximately $475–$488 million, representing a massive top-line miss.
KOS shares are down approximately 20% in premarket trading on March 11, 2026, having shed roughly 20.31% across the last two sessions (Tuesday close and premarket Wednesday). The primary catalyst is Kosmos Energy's announcement of a massive $185.25 million public equity offering priced at $1.90 per share — a steep discount to recent trading levels.
NBIS shares surged approximately +10% in premarket trading on March 11, 2026, from a prior close of $96.32. The primary catalyst is the imminent addition of Nebius Group to the Bloomberg 500 (B500) Index, effective prior to the open of trading on Thursday, March 12, 2026.
ORCL shares surged approximately +10.49% in Wednesday's premarket session, trading around $165.07 versus Tuesday's closing price of $149.40. The primary catalyst is Oracle's Q3 FY2026 earnings beat, with adjusted EPS of $1.79 vs. the $1.70 consensus estimate, and revenue of $17.2 billion topping the $16.92 billion forecast.
Shares of AngloGold Ashanti plc (AU) are down approximately 5.00% in early trading on March 11, 2026, falling from a prior close of $108.26 to around $102.85. The primary driver is a renewed pullback in gold prices, which has weighed heavily on gold mining equities across the board.
HMY shares are trading down approximately 13% in early session trading on March 11, 2026, following the release of the company's H1 FY26 interim results. Revenue of R44.4 billion (~US$2.6 billion) missed analyst consensus estimates of R47.56 billion, a significant shortfall that spooked investors.
FICO fell over 9% today, extending a multi‑week downtrend that has already knocked the stock more than 7% lower since its last earnings update. The decline comes despite strong recent financial results, including double‑digit revenue growth, expanding margins, and repeated earnings beats.
RERE fell roughly 10% today, giving back a portion of its strong gains over the past year and month, as traders reacted to fresh earnings and guidance. The company delivered robust Q4 2025 results, with revenue growth near 30% year over year and earnings per share ahead of consensus estimates, underscoring continued operational momentum.
Top hedge funds like Millennium, Citadel, and Bridgewater showed limited direct accumulation of penny stocks in Q4 2025 13F filings, but rotations into biotech, energy, and defense sectors highlight indirect interest in low-priced plays under $5. New entries and increased positions focused on volatile sectors like biotech (e.g., ABCL) and energy (e.g., AMPY), with full exits from overvalued names signaling a hunt for undervalued pennies amid market uncertainty.
Penny stocks in the oil sector are exploding in trading volume amid a massive oil price rally, with the USO ETF hitting a record $12.4 billion in daily trades—up 1,000% YTD and surpassing peaks from 2020, 2022, and 2025. Geopolitical tensions from the ongoing Iran war are driving oil above $100 per barrel, creating supply shocks and opportunities for high-volatility plays in exploration, drilling, and production.
NTSK shares are trading down approximately 20% in premarket trading on March 12, 2026, following the company's Q4 fiscal 2026 earnings release after the close on March 11. The primary catalyst is not the earnings themselves — which beat expectations — but an imminent and massive lock-up expiration scheduled for March 13, 2026, when approximately 390 million shares of Class A common stock become eligible for public sale.
PATH shares fell approximately 10% in premarket trading on March 12, 2026, reversing the prior session's 6.82% gain, as investors digested Q4 fiscal 2026 earnings released after the close on March 11. The primary catalyst for the selloff was disappointing FY2027 revenue guidance, which implies approximately 8–9% top-line growth — a notable deceleration from the 13% growth delivered in FY2026.
TIC shares are down approximately 15% in premarket trading on March 12, 2026, ahead of the regular session open. Primary catalyst: TIC Solutions reported Q4 2025 earnings before market open, posting an adjusted loss of $0.25 per share — a miss of $0.33 against the analyst consensus of -$0.08 per share.
HIMX shares surged approximately +33% in premarket trading on March 12, 2026, with the stock climbing from a prior close of $9.15 to around $12.19–$12.56. The primary catalyst is a renewed wave of AI-driven semiconductor enthusiasm surrounding Himax's Co-Packaged Optics (CPO) technology and its potential role as a supplier to major players including NVIDIA and Taiwan Semiconductor Manufacturing.
GIII shares fell approximately 15.65% in early trading on March 12, 2026, after the company reported its fiscal Q4 and full-year 2026 earnings before the bell. Q4 net sales dropped 8.1% year-over-year to $771.5 million, missing Wall Street's consensus estimate of approximately $792 million.
LWLG shares surged approximately 42% in early trading on March 12, 2026, building on a 15% rally from the prior session, as the stock's multi-day momentum accelerated into the regular open. The primary catalyst is Lightwave Logic's newly announced silicon photonics development agreement with Tower Semiconductor (TSEM), integrating its electro-optic polymer modulator technology into Tower's PH18 platform.
IperionX (NASDAQ: IPX) shares fell approximately 15% in Thursday's session, with the ADR trading around $42.70 after closing at $50.26 the prior session. The primary catalyst was the company's half-year financial report (H1 FY2026, ending December 31, 2025), which revealed a sharply wider net loss of US$34.8 million — more than double the US$16.2 million loss reported in the prior corresponding period.
SITM shares are down approximately 10% in Thursday's trading session, extending a multi-week decline from February highs near $447. The primary catalyst is a broad-based semiconductor sector selloff driven by intensifying tariff fears and macro uncertainty under the Trump administration's escalating trade policy.
RHLD shares dropped over 24% today, accelerating a recent downtrend that had already left the stock roughly 15–17% lower over the past month before today’s earnings‑driven selloff. For 2025, Resolute reported sales of about $462 million, up modestly from the prior year, but its net loss widened to roughly $5.9 million versus a $2.3 million loss in 2024.
VEON shares fell more than 14% today, a sharp reversal that follows a 12‑month gain of roughly 120% and year‑to‑date return near 45%, leaving the stock vulnerable to profit‑taking.​ The move comes just one day before VEON is scheduled to release its Q4 and full‑year 2025 results, prompting pre‑earnings de‑risking from traders who had enjoyed substantial gains.​